154 related articles for article (PubMed ID: 1828075)
1. In vivo additive antiretroviral effect of combined zidovudine and foscarnet therapy for human immunodeficiency virus infection (ACTG Protocol 053).
Jacobsen MA; van der Horst C; Causey DM; Dehlinger M; Hafner R; Mills J
J Infect Dis; 1991 Jun; 163(6):1219-22. PubMed ID: 1828075
[TBL] [Abstract][Full Text] [Related]
2. Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis.
Reddy MM; Grieco MH; McKinley GF; Causey DM; van der Horst CM; Parenti DM; Hooton TM; Davis RB; Jacobson MA
J Infect Dis; 1992 Sep; 166(3):607-10. PubMed ID: 1323624
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus.
Crowe SM; McGrath MS; Elbeik T; Kirihara J; Mills J
J Med Virol; 1989 Nov; 29(3):176-80. PubMed ID: 2533247
[TBL] [Abstract][Full Text] [Related]
4. Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects.
Mulder JW; Lange JM; de Wolf F; Houweling JT; Bakker M; Coutinho RA; Goudsmit J
Neth J Med; 1990 Aug; 37(1-2):4-10. PubMed ID: 2120599
[TBL] [Abstract][Full Text] [Related]
5. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
Davey RT; Davey VJ; Metcalf JA; Zurlo JJ; Kovacs JA; Falloon J; Polis MA; Zunich KM; Masur H; Lane HC
J Infect Dis; 1991 Jul; 164(1):43-52. PubMed ID: 1676045
[TBL] [Abstract][Full Text] [Related]
6. Zidovudine treatment of an infant with congenital human immunodeficiency virus infection.
Millard DD; Chadwick EG; Yogev R; Modlin JF
Pediatr Infect Dis J; 1990 Dec; 9(12):929-31. PubMed ID: 2126136
[No Abstract] [Full Text] [Related]
7. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine.
Williams IG; Gabriel G; Kelly G; Loveday C; Tedder RS; Weller IV
AIDS; 1990 Sep; 4(9):909-12. PubMed ID: 2123627
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine.
Berglund O; Engman K; Ehrnst A; Andersson J; Lidman K; Akerlund B; Sönnerborg A; Strannegård O
J Infect Dis; 1991 Apr; 163(4):710-5. PubMed ID: 1672701
[TBL] [Abstract][Full Text] [Related]
9. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J
J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921
[No Abstract] [Full Text] [Related]
10. Declining levels of HIV P24 antigen in serum during treatment with foscarnet.
Bergdahl S; Sönnerborg A; Larsson A; Strannegard O
Lancet; 1988 May; 1(8593):1052. PubMed ID: 2896890
[No Abstract] [Full Text] [Related]
11. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.
McKinney RE; Maha MA; Connor EM; Feinberg J; Scott GB; Wulfsohn M; McIntosh K; Borkowsky W; Modlin JF; Weintrub P
N Engl J Med; 1991 Apr; 324(15):1018-25. PubMed ID: 1672443
[TBL] [Abstract][Full Text] [Related]
12. Treatment of CMV retinitis.
Skolnik PR
N Engl J Med; 1992 Jun; 326(25):1701; author reply 1702-3. PubMed ID: 1317010
[No Abstract] [Full Text] [Related]
13. Zidovudine in the management of primary HIV-1 infection.
Tindall B; Gaines H; Imrie A; von Sydow MA; Evans L; Strannegard O; Tsang ML; Lindback S; Cooper DA
AIDS; 1991 May; 5(5):477-84. PubMed ID: 1907459
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
Staszewski S; Loveday C; Picazo JJ; Dellarnonica P; Skinhøj P; Johnson MA; Danner SA; Harrigan PR; Hill AM; Verity L; McDade H
JAMA; 1996 Jul; 276(2):111-7. PubMed ID: 8656502
[TBL] [Abstract][Full Text] [Related]
15. Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease.
Matthews SJ; Cersosimo RJ; Spivack ML
Pharmacotherapy; 1991; 11(6):419-48; discussion 448-9. PubMed ID: 1722897
[TBL] [Abstract][Full Text] [Related]
16. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
;
N Engl J Med; 1992 Jan; 326(4):213-20. PubMed ID: 1345799
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
Katlama C; Ingrand D; Loveday C; Clumeck N; Mallolas J; Staszewski S; Johnson M; Hill AM; Pearce G; McDade H
JAMA; 1996 Jul; 276(2):118-25. PubMed ID: 8656503
[TBL] [Abstract][Full Text] [Related]
18. Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus.
Schwartz DH; Skowron G; Merigan TC
J Acquir Immune Defic Syndr (1988); 1991; 4(1):11-23. PubMed ID: 1670586
[TBL] [Abstract][Full Text] [Related]
19. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
[TBL] [Abstract][Full Text] [Related]
20. Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activity.
de Jong MD; Loewenthal M; Boucher CA; van der Ende I; Hall D; Schipper P; Imrie A; Weigel HM; Kauffmann RH; Koster R
J Infect Dis; 1994 Jun; 169(6):1346-50. PubMed ID: 8195615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
